title: Consensus statement for the management of focal dystonias.
abstract: Focal dystonias include blepharospasm, torticollis, writer's cramp and laryngeal dystonia. They are not uncommon and are disabling. Botulinum toxin has recently been developed for injection into the muscles in spasm and can relieve symptoms in many patients.
authors.affiliation: University Department and Regional Centre for Neurology, Queen Elizabeth Hospital, Edgbaston, Birmingham.
authors.forename: A
authors.initials: A
authors.lastname: Williams
mesh_terms: D001905:Botulinum Toxins / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D009069:Movement Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology
chemical_list: D001905:Botulinum Toxins